1 |
502-61-4 |
NR3C1 |
|
qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway |
Active |
|
2 |
502-61-4 |
NR3C1 |
|
qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway |
Active |
|
3 |
502-61-4 |
NR3C1 |
|
qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway |
Active |
|
4 |
502-61-4 |
NR3C1 |
|
qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary |
Active |
|
5 |
502-61-4 |
NR3C1 |
|
qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary |
Active |
|
6 |
502-61-4 |
NR3C1 |
|
qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary |
Active |
|
7 |
502-61-4 |
|
|
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line |
Active |
|
8 |
502-61-4 |
|
|
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line |
Active |
|
9 |
502-61-4 |
|
|
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line |
Active |
|
10 |
502-61-4 |
|
|
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line |
Active |
|
11 |
502-61-4 |
|
|
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line |
Active |
|
12 |
502-61-4 |
|
|
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line |
Active |
|
13 |
502-61-4 |
PPARG |
|
qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary |
Active |
|
14 |
502-61-4 |
PPARG |
|
qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary |
Active |
|
15 |
502-61-4 |
PPARG |
|
qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary |
Active |
|
16 |
502-61-4 |
NFE2L2 |
|
qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway |
Active |
|
17 |
502-61-4 |
NFE2L2 |
|
qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway |
Active |
|
18 |
502-61-4 |
NFE2L2 |
|
qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway |
Active |
|
19 |
502-61-4 |
NFE2L2 |
|
qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary |
Active |
|
20 |
502-61-4 |
NFE2L2 |
|
qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary |
Active |
|
21 |
502-61-4 |
NFE2L2 |
|
qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary |
Active |
|
22 |
502-61-4 |
HSPB1 |
|
qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary |
Active |
|
23 |
502-61-4 |
HSPB1 |
|
qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary |
Active |
|
24 |
502-61-4 |
HSPB1 |
|
qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary |
Active |
|
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|
1 | | |
|
502-61-4 |
(E,E)-Farnesene |
Plant Variety and Essential oils